Prostate cancer detected at routine sextant biopsy in men in the placebo arm of the Prostate Cancer Prevention Trial, with negative digital rectal examination and serum prostate-specific antigen <4 ng/ml [18].
Prostate cancer detected at routine sextant biopsy in men in the placebo arm of the Prostate Cancer Prevention Trial, with negative digital rectal examination and serum prostate-specific antigen <4 ng/ml [18].